Diagnostic Code 7915 · 38 CFR §4.119
DC 7915 covers benign (non-cancerous) tumors of any endocrine gland. These include pituitary adenomas, adrenal adenomas, parathyroid adenomas, and other non-malignant endocrine growths. Although benign, these tumors often produce excess hormones that cause significant health problems. A pituitary adenoma might cause acromegaly or excess prolactin; an adrenal adenoma might cause Cushing syndrome or hyperaldosteronism. The tumor itself may be benign, but its effects can be quite disabling.
| Rating | Criteria |
|---|---|
| See pathways% | DC 7915 has no native percentage scale. The VA rates benign endocrine tumors as residuals of endocrine dysfunction — meaning the rating is determined by the specific endocrine effects (e.g., hyperthyroidism under DC 7900 if a thyroid adenoma causes overproduction, or by the dysfunction caused by pressure/mass effects). Surgical removal residuals are rated under appropriate scar/surgery codes. |
Imaging showing the tumor location and size is essential. Hormone level testing documenting what the tumor is producing helps classify the effects. Treatment records for medication or surgery demonstrate management needs. Post-treatment hormone testing shows any resulting deficiencies. Service records connecting the tumor to service factors establish eligibility.
Yes. DC 7915 rates benign tumors based on residuals of endocrine dysfunction. If the tumor causes Cushing syndrome (rated up to 100% under DC 7907) or acromegaly (rated up to 100% under DC 7908), the rating reflects those effects. The combined rating from all affected systems can be substantial even though the tumor is non-cancerous.
Non-functioning endocrine tumors are still ratable if they cause problems through their size (pressing on nearby structures like the optic nerve) or if they require treatment. The pressure effects would be rated under the appropriate body system code for the affected organ.